Healthcare Industry News: pre-pandemic
News Release - May 4, 2021
Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume LaboratoriesLabs processing ~2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs
BREA, Calif., May 4, 2021 -- (Healthcare Sales & Marketing Network) -- Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day.
The clinical laboratory has gone through trial by fire in 2020, where total testing was 245% of baseline volumes, with ~55% being SARS-CoV-2 molecular tests.i According to the CDC, an estimated 41% of U.S. adults delayed or avoided medical careii. Despite vaccines, many industry players suggest SARS-CoV-2 testing volumes won't be impacted in the near term, and the demand for COVID-19-related testing will continue through 2021 and potentially into 2022iii. This means that testing-volume pressure on labs is going to continue.
Labs of all sizes are facing the same challenges: shortage of laboratory technologists and techniciansiv, historic financial pressures on hospitals and health systemsv, and physically and mentally exhausted laboratory professionalsvi – a pre-pandemic problem that has since been exacerbated. However, the TLA solutions that cater to labs processing high-sample volumes are out of reach for smaller volume labs due to space requirements and infrastructure constraints.
The Right Fit for Mid-sized Labs
"When we look at automation for our labs it's a balancing act between system throughput capacity, test menu and footprint of the system," said Afruj Ruf, managing director at Integrated Pathology Solutions LLP, Airedale NHS Foundation Trust. "At the Harrogate District Hospital site, we knew that a large automated system will be too large and excessive and a standalone system doesn't give us the streamlined workflow we want. What we needed was a compact automation system that reduced the number of steps, requiring minimum human intervention and generated a valid result at first pass so that our lab professionals are not moving samples around but performing the valuable scientific tasks they are trained for. From its compact footprint and minimizing manual work by 80%, to intelligent routing that makes sure our acute patients get their results faster than routine ones, the DxA 5000 Fit was just the right fit for us."
In a survey, lab directors and managers were asked to identify the key challenges hospital labs are facing. The results found that staffing (26 percent) and turnaround time (23 percent) were identified as top prioritiesvii. Automation plays a key role in helping to address many of these issues while enabling precious resources to focus on high-value, clinical tasks – this has proven particularly true during the COVID-19 pandemicviii.
"For large laboratories, TLA is a reality today. However, for medium-volume labs like ours that process fewer than 4,000 tests per day, comprehensive workflow-automation solutions haven't been an option," said Susan Enciso, System Supervisor of Chemistry, Excela Health. "Beckman Coulter's DxA 5000 Fit solution is the right fit for us. It has a flexible design which is important in a lab like ours where space is a precious commodity; and reduces our manual process steps by up to 80%, helping us meet today's unprecedented need for COVID-19 and routine tests."
With the DxA 5000 Fit, mid-sized labs can enjoy the same benefits as larger-volume labs:
- Comprehensive workflow automation to reduce up to 80% of manual steps through pre-analytical, analytical and post-analytical automationix, conserving precious human resources to do higher-value clinical work
- Intelligent routing with dynamically calculated route planning for rapid and consistent TAT, with STATs always prioritized to deliver results faster
- Flexible design that can be adapted to meet a mid-volume lab's space and infrastructure constraints
The DxA 5000 Fit is authorized for sale in the United States and most European and Asian countries.
"At Beckman Coulter, we believe that medium-size labs should be able to leverage the benefits of automation to address their challenges. Just because your lab is not processing a higher number of samples, doesn't mean you have to sacrifice the benefits of intelligent laboratory automation and settle for a marginally automated workcell-plus solution," said Dr. Peter Soltani, senior vice president & general manager, hematology, urinalysis & workflow information technology solutions at Beckman Coulter. "This is why we have launched DxA 5000 Fit, the first compact workflow automation solution that's the right fit for mid-volume labs because automation should be for all labs."
Learn more about Beckman Coulter's family of automation solutions and the DxA 5000 Fit on our website at www.beckmancoulter.com/automation.
You can access the media package for DxA 5000 Fit, which contains product videos, articles and other assets at www.beckmancoulter.com/DxA5000Fit-Media.
About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory's role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.
© 2021 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2021-8868
i Bonislawski, A. "The Clinical Lab in 2020: The Impact of COVID-19 This Year and Beyond." 360 Dx. December 29, 2020. https://www.360dx.com/clinical-lab-management/clinical-lab-2020-impact-covid-19-year-and-beyond [Accessed: March 1, 2021]
ii Czeisler MÉ, Marynak K, Clarke KE, et al. Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep 2020;69:1250–1257. DOI: http://dx.doi.org/10.15585/mmwr.mm6936a4.
iii Bonislawski, A. "How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?" 360 Dx. December 20, 2020. https://www.360dx.com/clinical-lab-management/how-will-labs-use-expanded-molecular-testing-capacities-post-covid-19 [Accessed: January 28, 2021]
iv Ford BA & McElavania E. "Machine Learning Takes Laboratory Automation to the Next Level." Journal of Clinical Microbiology. Mar 2020, 58 (4) e00012-20; DOI: 10.1128/JCM.00012-20
v Hospitals and Health Systems Face Unprecedented Financial Pressures Due to COVID-19. May 2020. American Hospital Association. https://www.aha.org/guidesreports/2020-05-05-hospitals-and-health-systems-face-unprecedented-financial-pressures-due [Accessed: March 1, 2021]
vi https://cbsaustin.com/news/local/medical-laboratory-professionals-perform-covid-19-tests-face-burnout-and-exhaustion [Accessed: March 1, 2021]
vii National Health System Crisis Readiness Report 2020 Edition. Accumen. August 27, 2020. https://ACCUMEN.com/crisis-report-2020 [Accessed October 6, 2020]
viii Gramz, J. "The benefits of lab automation to facilitate testing for SARS-CoV-2." November 19, 2020. https://www.mlo-online.com/continuing-education/article/21163060/the-benefits-of-lab-automation-to-facilitate-testing-for-sarscov2 [Accessed: March 1, 2021]
ix Based on Beckman Coulter analysis of typical clinical diagnostics laboratory workflow steps. Step counts may vary.
Source: Beckman Coulter
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.